When was Veramed founded?

Veramed was founded in 2012 and raised its 1st funding round 9 years after it was founded.

Where is Veramed located?

Veramed is headquartered in London, United Kingdom. It is registered at 5TH FLOOR REGAL HOUSE,LONDON ROAD,TWICKENHAM,ENGLAND,TW1 3QS.

How many employees does Veramed have?

As of Dec 31, 2017, the latest employee count at Veramed is 28.

Is Veramed a funded company?

Veramed is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Nov 08, 2021.

When was the latest funding round of Veramed?

Veramed's latest funding was a $***** Seed round on Nov 08, 2021, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. Globally, the Biopharma Outsourcing sector has seen $287M in funding in 2026 to date.

Where does Veramed rank among its competitors?

Veramed ranks 93rd amongst 336 active competitors, of which 15 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Dash Bio, which secured $11M in Jun, 2025.

Who are the top competitors of Veramed?

Veramed's top competitors include Nordic Bioscience, BioAgilytix and Solvias. Among them, Dash Bio secured the most recent funding round in June, 2025.

Veramed - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Website: veramed.co.uk
Registered Address: 5TH FLOOR REGAL HOUSE,LONDON ROAD,TWICKENHAM,ENGLAND,TW1 3QS

Key Metrics

Founded Year

2012

Location

London, United Kingdom

Stage

Seed

Latest Funding Round

Seed, Nov 08, 2021, $*****

Investors

Livingbridge

Ranked

93^rd among 336 active competitors

Employee Count

28 as on Dec 31, 2017

Investment & Acquisitions

CTDS

Similar Companies

Nordic Bioscience & 369 more

View Veramed's full profile

Veramed is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
VERAMED LIMITED CIN: 7195346 , United Kingdom, Active	Mar 18, 2010	-	70 (As on Dec 31, 2020)

Veramed has raised funding over 1 round. Its latest funding round was a Seed round on Nov 08, 2021 for $*****. 1 investor participated in its latest round. Veramed has 1 institutional investor.

Here is the list of recent funding rounds of Veramed:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 08, 2021	2025342	Seed	2922468	7172968	1620808	3369230

Access funding benchmarks and valuations. Sign up today!

View details of Veramed's funding rounds and investors

Veramed's employee count trend

Veramed has 28 employees as of Dec 17. The total employee count is 33.0% more than what it was in Dec 16. Here is Veramed's employee count trend over the years:

Uncover Veramed's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Veramed include Nordic Bioscience, BioAgilytix and Solvias. Here is the list of Top 10 competitors of Veramed, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nordic Bioscience 1996, Herlev (Denmark), Late Stage	Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform	-	KKR, Europa	62/100
2nd	BioAgilytix 2008, Durham (United States), Acquired	Global bioanalytical services leader, supporting drug development across various modalities	-	GHO Capital Partners, Caledonia Private Capital ... & 2 others	60/100
3rd	Solvias 1999, Kaiseraugst (Switzerland), Acquired	Developer and manufacturer of medical devices, cosmetics, agrochemicals, and chemicals	-	Water Street, Broadoak Capital Partners & 1 others	58/100
4th	Advion 1993, Ithaca (United States), Acquired	Mass spectrometry, chromatography, and purification solutions for scientific advancement	$45.6M	Aisling Capital, Polaris Partners & 3 others	50/100
5th	NCIMB 1982, United Kingdom, Early Stage	Provider of biorepository, microbial culture collection and microbiology services	$2.27M	The Scottish National Investment Bank, Maven Capital Partners ... & 2 others	49/100
6th	Alderley Analytical 2013, Stockport (United Kingdom), Acquired	Provider of bioanalytical services for drug development programs and testing	$869K	Pioneer Group, Northern Powerhouse Investment Fund ... & 3 others	49/100
7th	Kcas Bioanalytical Services 2014, Shawnee (United States), Acquired	Global bioanalytical CRO providing comprehensive drug development services and advanced assay capabilities	-	-	49/100
8th	Dash Bio 2024, Boston (United States), Series A	Provider of automated bioanalysis platform for accelerated clinical drug development	$17.5M	The Aligned Fund, Freestyle & 5 others	48/100
9th	NMS Labs 1970, Willow Grove (United States), Unfunded	Provider of bioanalytical and central lab services, with special expertise in clinical toxicology and forensic testing	-	-	48/100
10th	ImmunXperts 2014, Charleroi (Belgium), Acquired	CRO specializing in human immune system based bioassay development services	$1M	Biowin, Sambrinvest	47/100
93rd	Veramed 2012, London (United Kingdom), Seed	Provider of biostatistics and programming services	-	Livingbridge	30/100